Literature DB >> 24378785

EMA's parallel advice workshop bridges regulatory and reimbursement divide.

Suzanne Elvidge.   

Abstract

Mesh：

Year:  2014        PMID： 24378785     DOI： 10.1038/nrd4219

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

Review 1.  Bringing in health technology assessment and cost-effectiveness considerations at an early stage of drug development.

Authors:  Bengt Jönsson
Journal:  Mol Oncol       Date:  2014-10-23       Impact factor: 6.603

2.  Issues in assessing products for the treatment of hemophilia - the intersection between efficacy, economics, and ethics.

Authors:  Albert Farrugia; Declan Noone; Uwe Schlenkrich; Steffen Schlenkrich; Brian O'Mahony; Josephine Cassar
Journal:  J Blood Med       Date:  2015-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.